
Cancer drug price cuts take effect, set to save consumers ₹3,540 cr yearly
The story in brief
Revised Maximum Retail Prices (MRPs) for 1,364 anti-cancer formulations have taken effect, expected to save consumers ₹3,540.38 crore annually. The National Pharmaceutical Pricing Authority capped trade margins on 137 drugs, with some prices cut by over 50%, up to 96.45%.